Search
for
Sort by
Research 571–600 of 1000+
- K <sub>ATP</sub> Channels and Cardiovascular Disease
- Glutamine Metabolism Controls Stem Cell Fate Reversibility and Long-Term Maintenance in the Hair Follicle
- Tofacitinib in alopecia areata and HIV: A curious intersection of immunomodulation, hair regrowth, and hypertrichosis
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Successful treatment of alopecia universalis with abrocitinib: a case report
- Effective use of ustekinumab in a patient with concomitant psoriasis, vitiligo, and alopecia areata
- Delayed granulomatous eruption of the nose associated with ruxolitinib
- Tofacitinib Treatment in Patients With Active COVID-19 Infection
- Abrocitinib Treatment in Diffuse Alopecia Areata: A Case Report and a Literature Review
- High-throughput T cell receptor sequencing identifies clonally expanded CD8+ T cell populations in alopecia areata
- JAK1 gain-of-function variant causes alopecia areata, atopic dermatitis, and autoimmune thyroid disease
- Molecular Predictors of Ritlecitinib Efficacy in Alopecia Areata: Role of JAK3-Dependent Inflammation and Follicular Integrity
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Off-Label Uses of Abrocitinib: Review of Emerging Therapeutic Applications beyond Atopic Dermatitis
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Drugs targeting the JAK/STAT pathway for the treatment of immune-mediated inflammatory skin diseases: protocol for a scoping review
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- Tratamiento de la alopecia areata, un recorrido desde las opciones terapéuticas clásicas hasta los nuevos fármacos aparecidos en los últimos años
- Significant efficacy of tofacitinib from China in the treatment of alopecia areata: a case report
- Discoid lupus erythematosus successfully treated with deucravacitinib
- Unexpected Effect of Baricitinib Use: Observation of a Case of Hypertrichosis
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata